GLP-1 SM
GLP-1 SM is a 31-amino acid GLP-1 receptor agonist originally developed for type 2 diabetes, widely studied for its effects on glucose regulation, appetite suppression, and body weight reduction.
Free Shipping
over $200
Secure Checkout
256-bit SSL
Description
What is GLP-1 SM?GLP-1 SM is a synthetic peptide composed of 31 amino acids that shares 94% structural similarity with native human GLP-1 (glucagon-like peptide-1). GLP-1 SM is one of the most extensively studied incretin-based therapies in modern medicine.
The peptide features two amino acid substitutions and a C-18 fatty acid side chain that extends its half-life to approximately 7 days, compared to just 1.5 minutes for native GLP-1. This allows for once-weekly administration in clinical settings.
Semaglutide has been approved by the FDA under multiple brand names for type 2 diabetes and chronic weight management. It works by activating the GLP-1 receptor, which stimulates insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite.
Research-grade GLP-1 SM sold as a lyophilized peptide is not equivalent to FDA-approved formulations and is sold strictly for laboratory and research purposes only.
Research Applications
Areas of InvestigationGlucose Regulation
Body Weight & Appetite
Cardiovascular Research
Metabolic Syndrome
Compound Profile
Technical specificationsMolecular Profile
Form
Storage & Stability
Storage (Pre-Reconstitution)
Regulatory & Research Status
COA's (Certificate of Analysis)
Third Party Tested by Freedom DiagnosticsFrequently Asked Questions
Common questions about GLP-1 SM researchFast & SecureUS Shipping
Orders processed within 1 business day, with tracked delivery
Batch-LevelTraceability
Products tied to specific lot numbers and documentation
DedicatedResearch Support
Responsive assistance for documentation and order inquiriers
SecureCheckout
Encrypted transactions and protected customer data